Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy
Clinical trial NCT01094405 · COMPLETED
Trial details
- NCT number
- NCT01094405
- Sponsor
- Chinese University of Hong Kong
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-31
- Primary completion
- 2020-08-27
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.